Joshua Barney

(Page 4)

Deputy Public Information Officer

Josh primarily covers research and the School of Medicine. He previously worked at The Daily Progress newspaper in Charlottesville, Va., first as a reporter and then as an editor. He is a graduate of UVA.

Email | jdb9a@virginia.edu

Phone | 434.906.8864

Coverage Areas | Medical research, UVA School of Medicine

Posts by Joshua Barney

February 3, 2025 UVA Eyes Global Housing to Prevent Spread of Disease

A new computer model mapping the quality of housing construction in low- and middle-income countries will help prevent the spread of dangerous diseases.

January 29, 2025 Can Ketamine Stop Deadly Epilepsy Seizures?

UVA has received $9.3 million to test if ketamine can save patients from grand mal seizures that won’t respond to other treatments.

January 28, 2025 Durability of Surgery-Sparing Technique Shocks Scientists

A nanotechnology-based drug delivery system developed at UVA Health to save patients from repeated surgeries has proved to have unexpectedly long-lasting benefits in lab tests – a promising sign for its potential to help human patients.

MRI heart images created by UVA's new technique

January 23, 2025 UVA Develops Simple Scan to ID Patients at Heart Risk

Everyone knows the risks of carrying too much fat around the waist and hips, but we can now assess the risks of unseen fat around the heart.

January 22, 2025 SIDS Discovery Could ID Babies at Risk

School of Medicine research revealing the fingerprints of Sudden Infant Death Syndrome (SIDS) within blood samples could open the door to simple tests to identify babies at risk.

January 13, 2025 Computer Models Could Lead to More Targeted Antibiotics

New computer models created at the School of Medicine could give antibiotics a laser-like precision to target only specific bacteria in specific parts of the body.

December 18, 2024 Rett Syndrome Discovery Could Lead to Better Treatment

New discoveries about Rett syndrome could open the door to better treatments for the devastating, life-shortening developmental disorder.

David Schiff in the lobby of UVA's hospital.

December 3, 2024 Trial Identifies Better Treatment for Grade 2 Gliomas

Adding the chemotherapy pill temozolomide to radiation treatment significantly improves survival for adults with brain tumors known as grade 2 gliomas, a clinical trial led by a top UVA Health cancer expert has found.

November 21, 2024 Trial Tests Focused Ultrasound to Battle Melanoma

UVA's melanoma trial will evaluate the safety and effectiveness of using focused sound waves in conjunction with immunotherapy and surgery.

November 20, 2024 Weight-Loss Drug Tirzepatide Reduces Heart Failure Deaths

Tirzepatide, from pharmaceutical company Eli Lilly and Co., was tested in the SUMMIT clinical trial at 146 sites in the United States and abroad.